Following a successful global search by The RSA Group, Dr Emre Amirak has been appointed as Chief Medical Officer at Proveca, a UK-based pharmaceutical company which specialises in the development and licensing of medicines to address the unmet medical needs in children. Dr Amirak started his new position on 3rd June 2024.

Dr Amirak is a GMC registered medical doctor who brings together a wealth of clinical and industry experience to this key appointment. He is a strong strategic thinker and problem solver and passionate about developing medicines for children. Throughout his career he always aimed, and succeeded, in introducing new collaborative ways of working between medical and commercial, leading to improved business outcomes and patient benefits. With a successful track record of launching several drugs across UK, Ireland and the EMEA region, Emre will bring significant value to the CMO role at Proveca.

Dr Andy Theodorou, Senior Consultant at The RSA Group, commented, “It has been an absolute pleasure to partner with Dr Helen Shaw, CMO and co-founder of Proveca, to ensure we attract a talented individual who shares their passion for developing safe and efficacious paediatric medicines. Emre’s experience in drug development and proven track record of launching several medicines will be of great value in his new role at Proveca.”

Dr Helen Shaw, CMO at Proveca, said: “The role of Chief Medical Officer is very important in helping us to achieve our mission of developing medicines for children, and the fact that we have been able to attract an individual of Emre Amirak’s calibre is excellent news. We’d like to express our thanks to The RSA Group for their counsel at the early stage of the search, their help in navigating us through the process and in clearly establishing what Proveca needed from this role.”

Dr Emre Amirak commented: “It was a pleasure working with you and the RSA team during the appointment process, which was very thorough and meticulous. I’m delighted to join the team here and I’m looking forward to a long and exciting future with Proveca.”

ENDS

For further information, contact:
Dr Andy Theodorou
Senior Consultant, The RSA Group
E: Andy.Theodorou@theRSAGroup.com

Notes to Editors

About The RSA Group
Founded in 1981, we are the pre-eminent global executive search firm in Life Sciences and Healthcare. We provide a unique combination of Executive Search and Executive Interims from Director to Board Level. In addition to supporting clients with market due diligence, competitor benchmarking, and brand perception surveys, we also review organisations as part of our People & Organisation Advisory and recommend the best options for evolution across organisational design, talent acquisition, development, and succession planning. With offices globally, we offer clients and candidates alike our in-depth knowledge and understanding of the life sciences industry, as well as first class project execution. To learn more about The RSA Group, visit www.theRSAgroup.com.

Share this: